This phase 2 randomized clinical trial evaluates the safety, tolerability, and efficacy of viltolarsen in boys with Duchenne muscular dystrophy amenable to exon 53 skipping
from journals https://ift.tt/3gqTDlW
from journals https://ift.tt/3gqTDlW
Comments
Post a Comment